Wedbush analyst David Nierengarten downgrades Applied Genetic Techs (NASDAQ:AGTC) from Outperform to Neutral.
Wedbush Downgrades Applied Genetic Techs to Neutral
Wedbush analyst David Nierengarten downgrades Applied Genetic Techs (NASDAQ:AGTC) from Outperform to Neutral.
Related Posts
Apple Takes The Cake Again In China As Top Smartphone Seller Amid Odds
January 27, 5:48 PM
Apple Inc (NASDAQ:AAPL) became the leading smartphone seller in China in Q4, despite Covid disruptions and economic slowdown. Apple accounted for…
Robinhood Delivers ‘Solid End To 2023’: 5 Analysts Comment On Q4 Print, Outlook
February 14, 11:01 AM
Shares of Robinhood Markets Inc (NASDAQ: HOOD) gained in premarket trading on Wednesday, after the company’s upbeat results for the fourth quarter.
Atlantic Equities Upgrades Church & Dwight Co to Neutral, Announces $80 Price Target
February 6, 6:54 AM
Atlantic Equities analyst Edward Lewis upgrades Church & Dwight Co (NYSE:CHD) from Underweight to Neutral and announces $80 price target.